Workflow
Skyray Instrument(300165)
icon
Search documents
ST天瑞(300165) - 第六届董事会第十七次会议决议公告
2025-10-24 09:00
证券代码:300165 证券简称:ST天瑞 公告编号:2025-046 江苏天瑞仪器股份有限公司 第六届董事会第十七次会议决议公告 公司董事和高级管理人员认真审阅了公司《2025 年第三季度报告》,认为 公司《2025 年第三季度报告》能够真实准确完整地反映公司的实际情况,并且 公司的董事、高级管理人员对该定期报告出具了书面确认意见。有关公司《2025 年第三季度报告》的具体内容详见中国证券监督管理委员会指定创业板信息披露 网站巨潮资讯网(www.cninfo.com.cn);《2025 年第三季度报告披露提示性公告》 刊登于 2025 年 10 月 25 日的《证券时报》《中国证券报》《上海证券报》。 本议案已经审计委员会审议通过。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 江苏天瑞仪器股份有限公司(以下简称"公司")于 2025 年 10 月 10 日以 电子邮件方式向全体董事发出召开第六届董事会第十七次会议的通知。会议于 2025 年 10 月 23 日下午 2:00 在公司八楼会议室以现场表决和通讯表决相结合的 方式召开。 ...
天瑞仪器(300165) - 2025 Q3 - 季度财报
2025-10-24 08:55
Financial Performance - The company's revenue for Q3 2025 was ¥140,032,428.12, a decrease of 33.03% compared to the same period last year[5] - The net profit attributable to shareholders was ¥8,366,023.31, an increase of 3.95% year-on-year, while the net profit after deducting non-recurring items was ¥7,503,727.27, down 7.30%[5] - The company experienced a 26.15% decline in revenue for the first nine months of 2025, primarily due to a decrease in orders[10] - Total operating revenue decreased to ¥434,869,225.66 from ¥588,862,093.80, representing a decline of approximately 26.1% year-over-year[24] - Net profit for the period was a loss of ¥8,015,295.75, compared to a loss of ¥4,134,938.90 in the previous period[24] - The total comprehensive income amounted to -8,015,295.75, compared to -4,134,938.90 in the prior period, reflecting a decline in overall performance[25] Cash Flow and Liquidity - The operating cash flow for the year-to-date period reached ¥106,066,132.38, reflecting a significant increase of 110.18%[5] - The net cash flow from operating activities for the first nine months was ¥10,606.61 million, an increase of 110.18% compared to the previous year[13] - Cash flow from operating activities generated a net cash inflow of 106,066,132.38, up from 50,463,310.85 in the previous period, showing improved operational efficiency[26] - Cash inflow from investment activities was 18,680,158.21, a decrease from 45,048,763.76 in the prior period, indicating reduced investment returns[27] - Cash flow from financing activities resulted in a net outflow of -118,367,764.57, an improvement from -160,315,711.86 in the previous period, suggesting better management of financing[28] - The ending cash and cash equivalents balance was 90,120,173.08, compared to 116,070,501.80 at the end of the previous period, indicating a decrease in liquidity[28] Assets and Liabilities - Total assets at the end of Q3 2025 were ¥3,338,140,290.46, a decrease of 2.58% from the end of the previous year[5] - Total assets decreased to ¥3,338,140,290.46 from ¥3,426,462,827.56, a reduction of about 2.6%[22] - Total liabilities decreased to ¥2,020,121,873.42 from ¥2,101,346,449.07, a decline of approximately 3.9%[22] - Shareholders' equity decreased to ¥1,318,018,417.04 from ¥1,325,116,378.49, a slight decrease of about 0.5%[22] Shareholder Information - The total number of common shareholders at the end of the reporting period is 15,367[15] - Liu Zhaogui holds 16.13% of shares, totaling 79,914,203 shares, with 59,935,652 shares under lock-up[15] - Guangzhou Lidu Virtual Reality Technology holds 5.01% of shares, totaling 24,825,137 shares, with 19,890,844 shares frozen[15] - The total number of restricted shares at the beginning of the period was 74,977,046, with no changes during the period[17] - The top ten shareholders account for significant portions of the company's equity, with the largest shareholder holding over 16%[15] - The company has not reported any changes in the participation of major shareholders in margin trading[16] - There are no new developments regarding preferred shareholders or changes in restricted shares[16] - The company maintains a high level of lock-up shares for executives, with 75% of their holdings locked during their tenure[17] Research and Development - Research and development expenses decreased by 45.12% year-on-year, attributed to the completion of certain R&D projects[10] - Research and development expenses decreased to ¥30,726,901.26 from ¥55,991,492.78, a reduction of approximately 45% year-over-year[24] Earnings Per Share - The company reported a basic earnings per share of ¥0.0169, up 4.22% compared to the previous year[5] - Basic and diluted earnings per share were both -0.0025, an improvement from -0.0138 in the previous period, suggesting a positive trend in loss reduction[25]
ST天瑞(300165) - 关于公司股票被实施其他风险警示相关事项的进展公告
2025-10-09 08:36
证券代码:300165 证券简称:ST天瑞 公告编号:2025-044 江苏天瑞仪器股份有限公司 关于公司股票被实施其他风险警示相关事项的进展公告 1、江苏天瑞仪器股份有限公司(以下简称"公司")收到中国证监会出具的 《行政处罚事先告知书》并于2024年12月9日披露了《关于公司及相关当事人收 到<行政处罚事先告知书>的公告》(公告编号:2024-073)。根据《深圳证券交 易所创业板股票上市规则》第9.4条第(七)项规定,公司股票于2024年12月10 日起被实施其他风险警示。 2、公司于2025年3月18日收到中国证监会出具的《行政处罚决定书》 ([2025]40号),公司收到的《行政处罚决定书》中认定的情况与《行政处罚事 先告知书》中涉及的违法违规行为一致。 3、根据《深圳证券交易所创业板股票上市规则》第9.9条规定,公司因触及 第9.4条第七项情形,其股票交易被实施其他风险警示期间,应当至少每月披露一 次差错更正进展公告,直至披露行政处罚决定所涉事项财务会计报告更正公告及 会计师事务所出具的专项核查意见等文件。 一、实施其他风险警示的原因 公司于2024年12月6日收到中国证监会出具的《行政处罚事先告 ...
ST天瑞中标:浙江金华阳光招标代理有限公司关于金华市计量质量科学研究院X射线荧光光谱分析仪采购项目(非政府采购)的中标结果公告
Sou Hu Cai Jing· 2025-09-20 04:25
Group 1 - The core point of the article is the announcement of the successful bid by Jiangsu Tianrui Instrument Co., Ltd. for the procurement project of X-ray fluorescence spectrometer by Jinhua Metrology and Quality Inspection Institute [1][2] - The bid amount for the project is 165,000 [2] - Jiangsu Tianrui Instrument Co., Ltd. has participated in 928 bidding projects and has invested in 23 companies [1] Group 2 - The company holds 48 trademark registrations, 665 patents, and 143 copyright registrations [1] - Additionally, Jiangsu Tianrui Instrument has 34 administrative licenses [1]
ST天瑞(300165) - 上海市广发律师事务所关于江苏天瑞仪器股份有限公司2025年第二次临时股东大会法律意见书
2025-09-12 10:15
上海市广发律师事务所 关于江苏天瑞仪器股份有限公司 2025 年第二次临时股东大会的法律意见书 致:江苏天瑞仪器股份有限公司 江苏天瑞仪器股份有限公司(以下简称"公司")2025 年第二次临时股东 大会于 2025 年 9 月 12 日在江苏省昆山市中华园西路 1888 号天瑞大厦会议室召 开。上海市广发律师事务所经公司聘请,委派汤颖律师、占新越律师出席现场会 议,根据《中华人民共和国公司法》(以下简称"《公司法》")、《上市公司 股东会规则》(以下简称"《股东会规则》")等法律法规、其他规范性文件以 及《江苏天瑞仪器股份有限公司章程》(以下简称"《公司章程》")的规定, 就本次股东大会的召集和召开程序、召集人及出席会议人员的资格、会议议案、 表决方式和表决程序、表决结果和会议决议等出具本法律意见书。 本次股东大会是由公司董事会根据 2025 年 8 月 25 日召开的第六届董事会第 十六次会议决议召集。公司已于 2025 年 8 月 27 日在深圳证券交易所指定网站及 相关指定媒体上刊登了《江苏天瑞仪器股份有限公司关于召开 2025 年第二次临 时股东大会的通知》,并决定采取现场会议表决和网络投票相结合的方 ...
ST天瑞(300165) - 关于选举第六届董事会职工代表董事的公告
2025-09-12 10:14
证券代码:300165 证券简称:ST天瑞 公告编号:2025-043 江苏天瑞仪器股份有限公司 关于选举第六届董事会职工代表董事的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 江苏天瑞仪器股份有限公司董事会 二○二五年九月十二日 附件:贾立图女士简历 根据《中华人民共和国公司法》《深圳证券交易所创业板股票上市规则》《深 圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等 法律法规、规范性文件及《公司章程》的有关规定,江苏天瑞仪器股份有限公 司(以下简称"公司")于 2025 年 9 月 12 日召开了职工代表大会,经与会职工 代表审议,会议同意选举贾立图女士为公司第六届董事会职工代表董事(简历 详见附件)。贾立图女士由第六届董事会非独立董事变更为第六届董事会职工代 表董事,任期至第六届董事会任期届满之日。 本次选举完成后,公司董事会中兼任公司高级管理人员以及由职工代表担任 的董事人数总计未超过公司董事总数的二分之一,符合相关法律法规及《公司章 程》等的规定。 特此公告。 贾立图女士:中国国籍,无境外居留权,1980 年 1 月生 ...
ST天瑞(300165) - 2025年第二次临时股东大会决议公告
2025-09-12 10:14
证券代码:300165 证券简称:ST天瑞 公告编号:2025-042 江苏天瑞仪器股份有限公司 2025 年第二次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 特别提示: 1、本次股东大会未出现否决议案的情形。 (1)现场会议时间:2025 年 9 月 12 日(星期五)下午 15:00 (2)网络投票时间: ①通过深圳证券交易所交易系统进行网络投票的具体时间为:2025 年 9 月 12 日 9:15-9:25,9:30-11:30 和 13:00-15:00; ②通过深圳证券交易所互联网投票系统进行网络投票的具体时间为:2025 年 9 月 12 日 9:15 至 15:00 期间的任意时间。 2、现场会议召开地点:昆山市玉山镇中华园西路 1888 号天瑞大厦八楼会 议室。 3、会议召开方式:本次股东大会采取网络投票和现场表决相结合的方式召 开。 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 (一)会议召开情况 1、会议召开的时间: 4、会议召集人:公司董事会 5、会议主持人:董事长刘召贵先生 6、 ...
ST天瑞(300165) - 关于公司股票被实施其他风险警示相关事项的进展公告
2025-09-01 11:46
本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 二、采取的措施及进展情况 特别提示: 1、江苏天瑞仪器股份有限公司(以下简称"公司")收到中国证监会出具的 《行政处罚事先告知书》并于2024年12月9日披露了《关于公司及相关当事人收 到<行政处罚事先告知书>的公告》(公告编号:2024-073)。根据《深圳证券交 易所创业板股票上市规则》第9.4条第(七)项规定,公司股票于2024年12月10 日起被实施其他风险警示。 2、公司于2025年3月18日收到中国证监会出具的《行政处罚决定书》 ([2025]40号),公司收到的《行政处罚决定书》中认定的情况与《行政处罚事 先告知书》中涉及的违法违规行为一致。 3、根据《深圳证券交易所创业板股票上市规则》第9.9条规定,公司因触及 第9.4条第七项情形,其股票交易被实施其他风险警示期间,应当至少每月披露一 次差错更正进展公告,直至披露行政处罚决定所涉事项财务会计报告更正公告及 会计师事务所出具的专项核查意见等文件。 一、实施其他风险警示的原因 公司于2024年12月6日收到中国证监会出具的《行政处罚事先告知书》,根据 ...
ST天瑞2025年中报简析:亏损收窄,公司应收账款体量较大
Zheng Quan Zhi Xing· 2025-08-27 22:56
Group 1 - The core viewpoint of the article highlights the financial performance of ST Tianrui, indicating a significant decline in revenue and a negative net profit for the first half of 2025 [1] - The total operating revenue for the reporting period was 295 million yuan, a year-on-year decrease of 22.36%, while the net profit attributable to shareholders was -9.58 million yuan, an increase of 35.63% year-on-year [1] - In Q2, the operating revenue was 166 million yuan, down 31.63% year-on-year, and the net profit attributable to shareholders was -12.75 million yuan, a decline of 98.85% year-on-year [1] Group 2 - The company has a large amount of accounts receivable, with accounts receivable accounting for 53.46% of the total operating revenue in the latest annual report [1] - The gross profit margin was 44.76%, an increase of 10.44% year-on-year, while the net profit margin was -6.55%, a decrease of 83.28% year-on-year [1] - Total selling, administrative, and financial expenses amounted to 85.69 million yuan, representing 29.07% of revenue, an increase of 13.52% year-on-year [1] Group 3 - The company’s historical financial performance has been generally poor, with a median ROIC of 0.98% over the past decade and a particularly low ROIC of -5.33% in 2024 [2] - The business model relies heavily on marketing-driven performance, necessitating a thorough examination of the underlying drivers [2] - The company has reported four years of losses since its listing, indicating a lack of consistent profitability [2] Group 4 - The cash flow situation is concerning, with cash and cash equivalents accounting for only 3.07% of total assets and 18.6% of current liabilities [3] - The debt situation is also alarming, with an interest-bearing asset liability ratio of 37.9% and negative average operating cash flow over the past three years [3] - Financial expenses have been a consistent issue, with negative average net cash flow from operating activities over the past three years [3]
ST天瑞(300165)2025年中报简析:亏损收窄,公司应收账款体量较大
Sou Hu Cai Jing· 2025-08-27 22:37
Group 1 - The core viewpoint of the article highlights the financial performance of ST Tianrui, indicating a significant decline in revenue and a negative net profit for the first half of 2025 [1] - The total operating revenue for the reporting period was 295 million, a year-on-year decrease of 22.36%, while the net profit attributable to shareholders was -9.58 million, an increase of 35.63% year-on-year [1] - In Q2, the operating revenue was 166 million, down 31.63% year-on-year, and the net profit attributable to shareholders was -12.75 million, a decline of 98.85% year-on-year [1] Group 2 - The company reported a gross margin of 44.76%, which is an increase of 10.44% year-on-year, while the net margin was -6.55%, a decrease of 83.28% year-on-year [1] - Total selling, administrative, and financial expenses amounted to 85.69 million, accounting for 29.07% of revenue, which is an increase of 13.52% year-on-year [1] - The earnings per share was -0.02, an increase of 35.67% year-on-year, while the operating cash flow per share was 0.14, an increase of 232.41% year-on-year [1] Group 3 - The company has a significant amount of accounts receivable, with accounts receivable accounting for 53.46% of the latest annual revenue [1] - Historical data shows that the company's median ROIC over the past 10 years is 0.98%, indicating weak investment returns, with the worst year being 2024 at -5.33% [3] - The company relies heavily on marketing-driven performance, necessitating a thorough examination of the underlying factors driving this performance [3]